Research Article
Volume 13 Issue 2 - 2021
Gut Microbiome Changes with Osteopathic Treatment of Constipation in Parkinson’s Disease: A Pilot Study
Jayme D Mancini1*, Sheldon Yao1, Luis R Martinez2, Haque Shakil1 and To Shan Li1

1New York Institute of Technology College of Osteopathic Medicine, Northern Boulevard, Old Westbury, NY, USA

2Department of Oral Biology, University of Florida College of Dentistry, Gainesville, FL, USA

*Corresponding Author: Jayme D Mancini, New York Institute of Technology College of Osteopathic Medicine, Northern Boulevard, Old Westbury, NY, USA.
Received: November 18, 2020; Published: January 30, 2021




Abstract

Introduction: The gut microbiome appears to be predictive of Parkinson’s disease (PD) with constipation. Chronic constipation frequently manifests prior to motor symptoms and impairs quality of life. An osteopathic manipulative medicine (OMM) sequence used physical exam assessment and manual treatment of neuromusculoskeletal dysfunctions pertinent to constipation in PD for this prospective ABA-design study, IRB-NYITBHS1065. The effects of 4 weekly treatments on the gut microbiome among men and women over 40 years old with chronic constipation and PD were investigated. Severity of PD was rated with the Movement Disorders Society-Unified PD rating scale (UPDRS) in six subjects with constipation. Also, the Bristol stool scale and questionnaires validated for constipation were administered for diagnosis, symptom severity, and quality of life during a 4-week control-period (A), 4-weekly OMM-treatments (B), and 2-weeks no-intervention (A). Biweekly stool samples were assessed for normalized microbiota abundance.

Results: The mean Bristol rating improved from type 2 (± 1) Pre-OMM to 3 (± 1; p = .167; d = 0.677) Post-OMM. Mean constipation severity significantly decreased (p = .010; d = 1.508) Post-OMM. Mean quality of life significantly improved (p = .041; d = 1.072) Post-OMM. The Pre-OMM mean number of families within the phylum Firmicutes decreased by 3 (p = .043; d = 1.177) Post-OMM. There were significant changes in the normalized abundance of phyla Actinobacteria (p = .040; d = 0.845) and Verrucomicrobia (p = .024; d = 0.675) as well as in genus Roseburia (p = .033; d = 1.109), Intestinimonas (p = .035; d = 0.627) and Anaerotruncus (p = .004) Post-OMM.

Conclusion: The gut microbiome shifted among individuals with constipation and PD after four weekly treatments with the OMMsequence. Changes in the gut microbiome Post-OMM were associated with UPDRS results and constipation measures. Clinical trials and studies to develop the gut microbiome into a validated biomarker for PD are necessary to understand the impact of OMM in patients with PD and constipation.

 

Keywords: Parkinson’s Disease; Constipation; Manual Therapy; Microbiota; Gastrointestinal System; Autonomic Nervous System

References

      1. Verbaan D Marinus., et al. “Patient-reported autonomic symptoms in Parkinson's Disease”. Neurology 4 (2007): 333-341.
      2. Hou JG and Lai E. “Non-Motor Symptoms of Parkinson's Disease”. International Journal of Gerontology 2 (2007): 53-64.
      3. Asahina M., et al. “Autonomic dysfunction in parkinsonian disorders: assessment and pathophysiology”. Journal of Neurology, Neurosurgery, and Psychiatry 6 (2013): 674-680.
      4. Del Tredici K and Jost WH. “Gastrointestinal dysfunction in idiopathic Parkinson's disease”. Der Nervenarzt 10 (2012): 1282-1291.
      5. Nellesen D., et al. “A systematic review of the economic and humanistic burden of illness in irritable bowel syndrome and chronic constipation”. Journal of Managed Care and Specialty Pharmacy 9 (2013): 755-764.
      6. Scheperjans F., et al. “Gut microbiota are related to Parkinson’s disease and clinical phenotype”. Movement Disorders 3 (2015): 350-358.
      7. Unger MM., et al. “Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls”. Parkinsonism and Related Disorders (2016): 1e7.
      8. Zhu L Liu., et al. “Structural changes in the gut microbiome of constipated patients”. Physiological Genomics (2014).
      9. DiGiovanna EL., et al. “An Osteopathic Approach to Diagnosis and Treatment”. Philadelphia, PA: Lippincott Williams and Wilkins (2005).
      10. Brugman R., et al. “The effect of osteopathic treatment on chronic constipation-A pilot study”. The International Journal of Osteopathic Medicine 1 (2010): 17-23.
      11. Tarsuslu T Bol., et al. “The effects of Osteopathic treatment on constipation with cerebral palsy: a pilot study”. Journal of Manipulative and Physiological Therapeutics 8 (2009): 648-653.
      12. Pfeiffer RF. “Gastrointestinal dysfunction in Parkinson's disease”. Current Treatment Options in Neurology 54 (2018): 52.
      13. Hemarajata P and Versalovic J. “Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation”. Therapeutic Advances in Gastroenterology 1 (2013): 39-51.
      14. Mathers SE., et al. “Constipation and paradoxical puborectalis contraction in anismus and Parkinson's disease: A dystonic phenomenon?” Journal of Neurology, Neurosurgery, and Psychiatry 51 (1988): 1503-1507.
      15. Kuijpers HC., et al. “The spastic pelvic floor syndrome large bowel outlet obstruction caused by pelvic floor dysfunction: a radiological study”. The International Journal of Colorectal Disease 1 (1986): 44-48.
      16. Vrees MD and Weiss EG. “The evaluation of constipation”. Clinics in Colon and Rectal Surgery 2 (2005): 65-75.
      17. Krogh K., et al. “Management of chronic constipation in adults”. United European Gastroenterology Journal: SAGE Journals 4 (2017): 465-472.
      18. Baille G., et al. “Review: Ventilatory dysfunction in Parkinson’s disease”. The Journal of Parkinson's Disease 6 (2016): 463-471.
      19. Baille G., et al. “Early occurrence of inspiratory muscle weakness in Parkinson's disease”. PLoS ONE1 (2018): e0190400.
      20. O'Callaghan A and Walker R. “A review of pulmonary function in Parkinson’s disease”. Journal Parkinsonism Restless Legs Syndrome 8 (2018): 13-23.
      21. Coggrave M and Norton C. “Management of faecal incontinence and constipation in adults with central neurological disease”. The Cochrane Database of Systematic Reviews Intervention12 (2013): CD002115.
      22. Krogh K., et al. “Management of chronic constipation in adults”. United European Gastroenterology Journal: SAGE Journals 4 (2017): 465-472.
      23. Krogh K and Christensen P. “Neurogenic colorectal and pelvic floor dysfunction”. Best Practice and Research: Clinical Gastroenterology 4 (2009): 531-543.
      24. De Schryyer AM., et al. “Effects of regular physical activity on defecation pattern in middle-aged patients complaining of chronic constipation”. Scandinavian Journal of Gastroenterology 4 (2005): 422-429.
      25. Goldfinger MS., et al. “An osteopathic, non pharmacologic approach to Parkinson’s disease, restless leg syndrome and essential tremor”. Osteopathic Family Physician 6 (2017): 30-38.
      26. Simrén M. “Physical activity and the gastrointestinal tract”. European Journal of Gastroenterology and Hepatology 10 (2002): 1053-1056.
      27. Davies SC., et al. “Ultrasound quantitation of respiratory organ motion in the upper abdomen”. British Institute of Radiology 803 (1994): 1096-1102.
      28. Brandner ED., et al. “Physics contribution abdominal organ motion measures using 4D CT”. International Journal of Radiation Oncology, Biology, Physics 2 (2006): 554-560.
      29. Bove A., et al. “Consensus statement AIGO/SICCR: Diagnosis and treatment of chronic constipation and obstructed defecation (part I: Diagnosis)”. World Journal of Gastroenterology 14 (2012): 1555-1564.
      30. Izumi K. “The measures to evaluate constipation: a review article”. Gastroenterol Nursing2 (2014): 137-146.
      31. Marquis P., et al. “Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire”. Scandinavian Journal of Gastroenterology 40 (2005): 540-551.
      32. Riegler G and Esposito I. “Bristol Scale Stool Form. A still valid help in medical practice and clinical research”. Techniques in Coloproctology 3 (2001): 163-164.
      33. Lewis SJ and Heaton KW. “Stool form scale as a useful guide to intestinal transit time”. Scandinavian Journal of Gastroenterology 32 (1997): 920-924.
      34. Hoehn MM and Yahr MD. “Parkinsonism: onset, progression and mortality”. Neurology5 (1967): 427-442.
      35. Nicholas A and Nicholas E. “Atlas of Osteopathic Techniques”. 2nd Lippincott Williams and Wilkins Wolters Kluwer (2012): 86.
      36. Degenhardt BF., et al. “Characterizing adverse events reported immediately after osteopathic manipulative treatment”. The Journal of the American Osteopathic Association 3 (2018): 141-149.
      37. Akoglu H. “User's guide to correlation coefficients”. Turkish Journal of Emergency Medicine 18 (2018): 91-93.
      38. Willis AD. “Rarefaction, alpha diversity, and statistics”. Frontiers in Microbiology 10 (2019): 2407.
      39. Sullivan LM. “Statistical primer for cardiovascular research: Repeated measures”. Circulation AHA 117 (2008): 1238-1243.
      40. Hulley SB., et al. “Designing Clinical Research 3rd Edition”. Wolters Kluwer Health Lippincott Williams, and Wilkins Philadelphia, PA (2007).
      41. Thomson H., et al. “Applying the ROBINS-I tool to natural experiments: an example from public health”. Systematic Reviews 15 (2018).
      42. Tack J., et al. “Effect of prucalopride on symptoms of chronic constipation”. Neurogastroenterology and Motility 26 (2014): 21-27.
      43. Chumpitazi BP., et al. “Bristol Stool Form Scale reliability and agreement decreases when determining Rome III stool form designations”. Neurogastroenterology and Motility 3 (2016): 443-448.
      44. Frist WH., et al. “Expanding the use of Real-World Evidence in regulatory and value-based payment decision-making for drugs and biologics”. Bipartisan Policy Center (2019).
      45. Trull TJ and Ebner-Priemer UW. “Using experience sampling methods/ecological momentary assessment (ESM/EMA) in clinical assessment and clinical research: Introduction to the special section”. Psychological Assessment 4 (2009): 457-462.
Citation: Jayme D Mancini., et al. “Gut Microbiome Changes with Osteopathic Treatment of Constipation in Parkinson’s Disease: A Pilot Study”. EC Neurology 13.2 (2021): 19-33.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


April Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the April issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before April 26, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk